Search
Sanara Medtech Inc
SMTIAdd to Watchlist
33.860USD
-0.200-0.59%
Close 07-31 16:00（ET）Quotes delayed by 15 min
311.28MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Sanara Medtech Inc is 8.00, ranking 56 out of 155 in the Pharmaceuticals industry. The average price target is 41.00, with a high of 46.00 and a low of 36.00.
Analyst Rating
Based on
3
analysts
Hold
Current Rating
35.000
Target Price
+3.37%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Sanara Medtech Inc
SMTI
3
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Sanara Medtech Inc's expected revenue for the next quarter?
Sanara Medtech Inc's expected revenue is 28.95M.
What is Sanara Medtech Inc's price target?
Analysts forecast that Sanara Medtech Inc's price target is USD 41.00, with the highest forecast at USD 46.00 and the lowest forecast at USD 36.00.
How have Sanara Medtech IncSMTI's recent earnings per share performed?
The market expectation was USD 0.05, while Sanara Medtech IncSMTI's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.03.
What is the analyst rating for Sanara Medtech Inc?
Based on the ratings of Sanara Medtech Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.